BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10487799)

  • 21. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies.
    Nakamura K; Nakagawa H; Sakurai M; Murakami Y; Irie F; Fujiyoshi A; Okamura T; Miura K; Ueshima H;
    Cerebrovasc Dis; 2012; 33(5):480-91. PubMed ID: 22517421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential to reduce death by cardiological treatment.
    Rosolova H; Simon J
    Eur Heart J; 1999 Oct; 20(19):1376-7. PubMed ID: 10487797
    [No Abstract]   [Full Text] [Related]  

  • 24. Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    Eur J Public Health; 2007 Apr; 17(2):193-8. PubMed ID: 16798782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.
    Ford ES; Ajani UA; Croft JB; Critchley JA; Labarthe DR; Kottke TE; Giles WH; Capewell S
    N Engl J Med; 2007 Jun; 356(23):2388-98. PubMed ID: 17554120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac rehabilitation uptake and its determinants in the Netherlands.
    van Engen-Verheul M; de Vries H; Kemps H; Kraaijenhagen R; de Keizer N; Peek N
    Eur J Prev Cardiol; 2013 Apr; 20(2):349-56. PubMed ID: 22345699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010.
    Bennett K; Kabir Z; Barry M; Tilson L; Fidan D; Shelley E; Capewell S
    Value Health; 2009; 12(1):10-5. PubMed ID: 19040564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.
    Bennett K; Kabir Z; Unal B; Shelley E; Critchley J; Perry I; Feely J; Capewell S
    J Epidemiol Community Health; 2006 Apr; 60(4):322-7. PubMed ID: 16537349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.
    Unal B; Critchley JA; Capewell S
    Circulation; 2004 Mar; 109(9):1101-7. PubMed ID: 14993137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993.
    Capewell S; Beaglehole R; Seddon M; McMurray J
    Circulation; 2000 Sep; 102(13):1511-6. PubMed ID: 11004141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988-2005].
    Flores-Mateo G; Grau M; O'Flaherty M; Ramos R; Elosua R; Violan-Fors C; Quesada M; Martí R; Sala J; Marrugat J; Capewell S
    Rev Esp Cardiol; 2011 Nov; 64(11):988-96. PubMed ID: 21962958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in coronary heart disease--cautious optimism.
    Lorimer AR; Packhard CJ
    Scott Med J; 1993 Dec; 38(6):168. PubMed ID: 8146633
    [No Abstract]   [Full Text] [Related]  

  • 35. "I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data.
    Evans C; Chalmers J; Capewell S; Redpath A; Finlayson A; Boyd J; Pell J; McMurray J; Macintyre K; Graham L
    BMJ; 2000 Jan; 320(7229):218-9. PubMed ID: 10642230
    [No Abstract]   [Full Text] [Related]  

  • 36. The comparative effectiveness of heart disease prevention and treatment strategies.
    Kottke TE; Faith DA; Jordan CO; Pronk NP; Thomas RJ; Capewell S
    Am J Prev Med; 2009 Jan; 36(1):82-88. PubMed ID: 19095166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of risk factors for coronary heart disease morbidity versus mortality.
    Batty GD; Kivimäki M; Bell S
    Eur J Prev Cardiol; 2020 Dec; 27(19):2232-2234. PubMed ID: 31619085
    [No Abstract]   [Full Text] [Related]  

  • 38. Can coronary heardisease be prevented?
    Doyle JT
    Am J Med Sci; 1969 Aug; 258(2):67-9. PubMed ID: 5805235
    [No Abstract]   [Full Text] [Related]  

  • 39. Why has mortality from coronary heart disease in young adults levelled off?
    Leyland AH; Lynch JW
    BMJ; 2009 Jul; 339():b2515. PubMed ID: 19602712
    [No Abstract]   [Full Text] [Related]  

  • 40. Latitude and heart disease.
    Williams FL; Lloyd OL
    Lancet; 1989 May; 1(8646):1072-3. PubMed ID: 2566014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.